Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Sny crawled date : 2021 - 08 - 06 save search
Muscular Dystrophy Association Celebrates FDA Approval of (Nexviazyme) for Treatment of Pompe disease
Published: 2021-08-06 (Crawled : 21:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
disease treatment fda fda approval approval
Global Pediatric Vaccine Market Research Report 2021: Market is Expected to Reach $49.9 Billion in 2025 - Long-term Forecast to 2030
Published: 2021-08-06 (Crawled : 17:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.54%
H: 0.18%
C: -1.21%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -4.5%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.95%
H: 0.23%
C: -0.3%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -2.02%
H: 0.09%
C: -1.38%
vaccine research
FDA approves Nexviazyme® (avalglucosidase alfa-ngpt), an important new treatment option for late-onset Pompe disease
Published: 2021-08-06 (Crawled : 16:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
disease treatment fda fda approval
Global Oral Biologics & Biosimilar Drugs Markets 2021-2030: Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis
Published: 2021-08-06 (Crawled : 15:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -4.5%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.95%
H: 0.23%
C: -0.3%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
ENTX | $1.985 -11.38% -12.85% 300K
|
Health Technology
|
| O: 2.23%
H: 0.0%
C: -1.39%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -2.02%
H: 0.09%
C: -1.38%
RVP P | $1.06 0.95% 0.0% 84K
|
Health Technology
|
| O: -0.08%
H: 1.82%
C: 0.87%
multiple sclerosis disease diabetes drug sclerosis psoriasis biosimilar
Drug Delivery Devices Global Markets Report 2021: COVID-19 Impacts, Implications and Growth Factors to 2030
Published: 2021-08-06 (Crawled : 15:00) - prnewswire.com
WST | $372.04 -1.4% 0.0% 440K
|
Health Technology
|
| O: -0.71%
H: 1.44%
C: 1.15%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.85%
H: 0.15%
C: -0.16%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.95%
H: 0.23%
C: -0.3%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: 0.0%
MMM | $92.27 0.86% -0.18% 3.6M
|
Producer Manufacturing
|
| O: 0.19%
H: 0.54%
C: -0.03%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: -2.24%
PODD | $166.255 0.93% 0.92% 840K
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: -2.64%
covid drug growth device drug delivery liver
Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update
Published: 2021-08-06 (Crawled : 12:15) - globenewswire.com
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.04%
H: 0.01%
C: -0.39%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
REPL | $6.47 -7.17% -7.73% 870K
|
Health Technology
|
| O: 1.76%
H: 0.0%
C: -11.93%
financial results results
Kymera Therapeutics Announces Second Quarter 2021 Financial Results and Provides a Business Update
Published: 2021-08-06 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: -5.0%
financial results results
The Galien Foundation Debuts 2021 Prix Galien USA Nominees in "Best Biotechnology Product," "Best Pharmaceutical Agent," "Best Medical Technology" and "Best Digital Health Solution" Categories
Published: 2021-08-06 (Crawled : 04:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.54%
H: 0.18%
C: -1.21%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -4.5%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
GKOS | $96.5 1.44% 0.0% 700K
|
Health Technology
|
| O: -4.43%
H: 5.13%
C: 4.76%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: 0.13%
H: 0.06%
C: -0.02%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.1%
H: 1.97%
C: 1.29%
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: -0.34%
H: 0.04%
C: -6.6%
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: -1.14%
H: 2.45%
C: 1.76%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.23%
H: 0.14%
C: -0.52%
EIGR | $1.725 -1.45% 140K
|
Health Technology
|
| O: -1.82%
H: 4.94%
C: 4.33%
biotech technology iot
Tenders for the win: four strategies that will improve your bids
Published: 2021-08-05 (Crawled : 00:00) - modeln.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.